Dubai, United Arab Emirates – The Dubai Branch of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that it will bring its latest innovations at this year’s Medlab Middle East, the region’s renowned medical laboratory exhibition taking place from June 21-24, 2021.

“Last year, the world was exposed to undesirable medical extremities,” said Maher Elhassan, Vice President & General Manager, BD Middle East, North Africa & Turkey. “Now is the time when communities in the region and throughout the world need our continued support and expertise to be able to fight all adversaries and recover. As part of our mission to advance the world of health, BD is determined to leave no stone unturned in our quest to impact people’s lives. Our participation at Medlab Middle East reiterates the company’s efforts to support the region’s healthcare sector with our latest innovations that deliver on patient care, safety, diagnostic accuracy, automation and more.”

Through its unprecedented efforts and innovation drive, over the years BD has brought about a significant transformation in the field of medical technology. During Medlab, the company will showcase its latest MedTech innovations such as rapid diagnostic testing solutions to enable caregivers perform high number of tests in a short duration of time; advanced informatics and integrated diagnostics to enhance testing, automate workflows and help expedite decision-making; cutting-edge solutions for microbiology testing to facilitate rapid implementation of infection prevention and control measures; as well as microbiology automation amongst others.

Experts from the BD team will also be present at the company’s booth to host various in-depth sessions, share best practices, and demonstrate an array of innovative solutions to tackle the region’s ongoing healthcare challenges.

“The healthcare sector continues to face challenges ranging from shortage of skilled staff, rising costs, and lack of real time insights that can enable better patient outcomes,” said Shahzad Khan, Regional Business Director EMA, BD Integrated Diagnostic Solutions. “Some of the innovations that we will showcase at this year’s Medlab speak directly to these challenges. Therefore I invite industry professionals to attend the live demonstrations and gain first-hand knowledge on how to overcome such obstacles, and help reshape the future of healthcare.”

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.